These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition. Neutel JM Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme inhibitors and endothelial dysfunction. Carretaro OA Am J Hypertens; 1995 May; 8(5 Pt 2):42S-44S. PubMed ID: 7646843 [No Abstract] [Full Text] [Related]
6. [Role of the endothelium in the control of vascular motility: physiologic aspects and physiopathologic implications in cardiovascular diseases]. Limone P; Boeri E; Molinatti GM Minerva Med; 1993 Oct; 84(10):499-505. PubMed ID: 8247303 [TBL] [Abstract][Full Text] [Related]
8. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function. Neutel JM J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263 [TBL] [Abstract][Full Text] [Related]
9. [Vascular endothelium: target organ of cardiovascular pathologies]. Berkenboom G Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):643-6. PubMed ID: 12555471 [TBL] [Abstract][Full Text] [Related]
10. The importance of managing cardiovascular risk in the treatment of hypertension: the role of ACE inhibitors and ARBs. Pierson CA; Epstein BJ; Roberts ME J Am Acad Nurse Pract; 2008 Nov; 20(11):529-38. PubMed ID: 19128336 [No Abstract] [Full Text] [Related]
11. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851 [TBL] [Abstract][Full Text] [Related]
13. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors. Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661 [TBL] [Abstract][Full Text] [Related]
14. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function. Izzo JL Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286 [TBL] [Abstract][Full Text] [Related]
15. Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy. Kakar P; Lip GY Expert Rev Cardiovasc Ther; 2007 May; 5(3):441-50. PubMed ID: 17489669 [TBL] [Abstract][Full Text] [Related]
16. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors. Galderisi M; de Divitiis O J Cardiovasc Pharmacol; 2008 Jun; 51(6):523-31. PubMed ID: 18520954 [TBL] [Abstract][Full Text] [Related]
17. Targeting endothelial dysfunction in hypertensive subjects. Thuillez C; Richard V J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029 [TBL] [Abstract][Full Text] [Related]
18. [Influence of ACE inhibitors and fibrates on endothelial function]. Januszewicz A Kardiol Pol; 2005 Jun; 62 Suppl 2():II60-4. PubMed ID: 19813338 [No Abstract] [Full Text] [Related]
19. Long-term use of angiotensin-converting enzyme inhibitors to modify endothelial dysfunction: a review of clinical investigations. Mancini GB Clin Invest Med; 2000 Apr; 23(2):144-61. PubMed ID: 10852664 [TBL] [Abstract][Full Text] [Related]
20. [Endothelium--a new target for a therapeutic action of angiotensin-converting enzyme inhibitors]. Karpov IuA Ter Arkh; 2004; 76(6):94-6. PubMed ID: 15332589 [No Abstract] [Full Text] [Related] [Next] [New Search]